These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12100730)

  • 1. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.
    Bramwell VW; Eyles JE; Somavarapu S; Alpar HO
    Immunology; 2002 Jul; 106(3):412-8. PubMed ID: 12100730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-mediated DNA vaccination: the effect of vesicle composition.
    Perrie Y; Frederik PM; Gregoriadis G
    Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
    McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
    Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated DNA vaccination.
    Gregoriadis G; Saffie R; de Souza JB
    FEBS Lett; 1997 Feb; 402(2-3):107-10. PubMed ID: 9037176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral plasmid DNA delivery systems for genetic immunisation.
    Somavarapu S; Bramwell VW; Alpar HO
    J Drug Target; 2003; 11(8-10):547-53. PubMed ID: 15203924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Dutta T; Garg M; Jain NK
    Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based immunization against the envelope proteins of the hepatitis B virus.
    Mancini M; Davis H; Tiollais P; Michel ML
    J Biotechnol; 1996 Jan; 44(1-3):47-57. PubMed ID: 8717386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
    Cui Z; Mumper RJ
    Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex.
    Wang J; Hu JH; Li FQ; Liu GZ; Zhu QG; Liu JY; Ma HJ; Peng C; Si FG
    Exp Dermatol; 2007 Sep; 16(9):724-9. PubMed ID: 17697144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
    Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to hepatitis B surface antigen following epidermal powder immunization.
    Osorio JE; Zuleger CL; Burger M; Chu Q; Payne LG; Chen D
    Immunol Cell Biol; 2003 Feb; 81(1):52-8. PubMed ID: 12534946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
    Schirmbeck R; Reimann J
    Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization.
    Wu L; Yuan ZH; Liu F; Waters JA; Wen YM
    Viral Immunol; 2001; 14(4):359-67. PubMed ID: 11792065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.